The cGAS/STING pathway: a sensor of senescence-associated DNA damage and trigger of inflammation in early age-related macular degeneration

References

• Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147–1159. doi:10.1016/S0140-6736(18)31550-230303083
   PubMed Web of Science ®Google Scholar
• Kaur G, Tan LX, Rathnasamy G, et al. Aberrant early endosome biogenesis mediates complement activation in the retinal pigment epithelium in models of macular degeneration. Proc Natl Acad Sci U S A. 2018;115(36):9014–9019. doi:10.1073/pnas.180503911530126999
   PubMed Web of Science ®Google Scholar
• Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol. 2003;87(3):312–317. doi:10.1136/bjo.87.3.31212598445
   PubMed Web of Science ®Google Scholar
• Wang C, Seo SJ, Kim JS, et al. Intravitreal implantable magnetic micropump for on-demand VEGFR-targeted drug delivery. J Control Release. 2018;283:105–112. doi:10.1016/j.jconrel.2018.05.03029852193
   PubMed Web of Science ®Google Scholar
• Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355(14):1432–1444. doi:10.1056/NEJMoa06265517021319
   PubMed Web of Science ®Google Scholar
• Saunier V, Merle BMJ, Delyfer MN, et al. Incidence of and risk factors associated with age-related macular degeneration: four-year follow-up from the ALIENOR study. JAMA Ophthalmol. 2018;136(5):473–481. doi:10.1001/jamaophthalmol.2018.050429596588
   PubMed Web of Science ®Google Scholar
• Ferrara N, Hillan KJ, Gerber HP, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov. 2004;3(5):391–400. doi:10.1038/nrd138115136787
   PubMed Web of Science ®Google Scholar
• Buitendijk GHS, Schauwvlieghe AME, Vingerling JR, Schlingemann RO, Klaver CCW, Comparing Bevacizumab to Ranibizumab in Age-related macular degeneration Trial Research G. Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial. Am J Ophthalmol. 2018;187:130–137. doi:10.1016/j.ajo.2018.01.00329330064
   PubMed Web of Science ®Google Scholar
• Mehta H, Tufail A, Daien V, et al. Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors. Prog Retin Eye Res. 2018;65:127–146. doi:10.1016/j.preteyeres.2017.12.00229305324
   PubMed Web of Science ®Google Scholar
• Amoaku WM, Chakravarthy U, Gale R, et al. Defining response to anti-VEGF therapies in neovascular AMD. Eye (Lond). 2015;29(6):721–731. doi:10.1038/eye.2015.4825882328
   PubMed Web of Science ®Google Scholar
• Delplace V, Payne S, Shoichet M. Delivery strategies for treatment of age-related ocular diseases: from a biological understanding to biomaterial solutions. J Control Release. 2015;219:652–668. doi:10.1016/j.jconrel.2015.09.06526435454
   PubMed Web of Science ®Google Scholar
• Khandhadia S, Cipriani V, Yates JR, Lotery AJ. Age-related macular degeneration and the complement system. Immunobiology. 2012;217(2):127–146. doi:10.1016/j.imbio.2011.07.01921868123
   PubMed Web of Science ®Google Scholar
• Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134(3):411–431.12208254
   PubMed Web of Science ®Google Scholar
• Zarbin MA, Rosenfeld PJ. Pathway-based therapies for age-related macular degeneration: an integrated survey of emerging treatment alternatives. Retina. 2010;30(9):1350–1367. doi:10.1097/IAE.0b013e3181f57e3020924259
   PubMed Web of Science ®Google Scholar
• Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology. 2014;121(3):693–701. doi:10.1016/j.ophtha.2013.09.04424289920
   PubMed Web of Science ®Google Scholar
• Thomas TC, Rollins SA, Rother RP, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol. 1996;33(17–18):1389–1401.9171898
   PubMed Web of Science ®Google Scholar
• Rhoades W, Dickson D, Do DV. Potential role of lampalizumab for treatment of geographic atrophy. Clin Ophthalmol. 2015;9:1049–1056. doi:10.2147/OPTH.S5972526089637
   PubMedGoogle Scholar
• Narayanan R, Kuppermann BD. Hot topics in dry AMD. Curr Pharm Des. 2017;23(4):542–546. doi:10.2174/138161282266616122115442428003009
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study 2 Research G. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the age-related eye disease study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015. doi:10.1001/jama.2013.499723644932
   PubMed Web of Science ®Google Scholar
• Wu J, Cho E, Giovannucci EL, et al. Dietary intake of alpha-linolenic acid and risk of age-related macular degeneration. Am J Clin Nutr. 2017;105(6):1483–1492. doi:10.3945/ajcn.116.14345328468892
   PubMed Web of Science ®Google Scholar
• Wu J, Cho E, Giovannucci EL, et al. Dietary intakes of eicosapentaenoic acid and docosahexaenoic acid and risk of age-related macular degeneration. Ophthalmology. 2017;124(5):634–643. doi:10.1016/j.ophtha.2016.12.03328153441
   PubMed Web of Science ®Google Scholar
• Datta S, Cano M, Ebrahimi K, Wang L, Handa JT. The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res. 2017;60:201–218. doi:10.1016/j.preteyeres.2017.03.00228336424
   PubMed Web of Science ®Google Scholar
• Corso-Diaz X, Jaeger C, Chaitankar V, Swaroop A. Epigenetic control of gene regulation during development and disease: A view from the retina. Prog Retin Eye Res. 2018;65:1–27. doi:10.1016/j.preteyeres.2018.03.00229544768
   PubMed Web of Science ®Google Scholar
• Toomey CB, Johnson LV, Bowes Rickman C. Complement factor H in AMD: bridging genetic associations and pathobiology. Prog Retin Eye Res. 2018;62:38–57. doi:10.1016/j.preteyeres.2017.09.00128928087
   PubMed Web of Science ®Google Scholar
• Cascella R, Ragazzo M, Strafella C, et al. Age-related macular degeneration: insights into inflammatory genes. J Ophthalmol. 2014;2014:582842. doi:10.1155/2014/58284225478207
   PubMed Web of Science ®Google Scholar
• Corominas J, Colijn JM, Geerlings MJ, et al. Whole-exome sequencing in age-related macular degeneration identifies rare variants in COL8A1, a component of Bruch’s membrane. Ophthalmology. 2018;125(9):1433–1443. doi:10.1016/j.ophtha.2018.03.04029706360
   PubMed Web of Science ®Google Scholar
• Yan Q, Ding Y, Liu Y, et al. Genome-wide analysis of disease progression in age-related macular degeneration. Hum Mol Genet. 2018;27(5):929–940. doi:10.1093/hmg/ddy00229346644
   PubMed Web of Science ®Google Scholar
• Cascella R, Strafella C, Longo G, et al. Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: significant association of twelve variants. Oncotarget. 2018;9(8):7812–7821. doi:10.18632/oncotarget.2324129487693
   PubMedGoogle Scholar
• DeAngelis MM, Owen LA, Morrison MA, et al. Genetics of age-related macular degeneration (AMD). Hum Mol Genet. 2017;26(R1):R45–R50. doi:10.1093/hmg/ddx22828854576
   PubMed Web of Science ®Google Scholar
• Hurley SF, Matthews JP, Guymer RH. Cost-effectiveness of smoking cessation to prevent age-related macular degeneration. Cost Eff Resour Alloc. 2008;6:18. doi:10.1186/1478-7547-6-1818783631
   PubMedGoogle Scholar
• Espinosa-Heidmann DG, Suner IJ, Catanuto P, Hernandez EP, Marin-Castano ME, Cousins SW. Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Invest Ophthalmol Vis Sci. 2006;47(2):729–737. doi:10.1167/iovs.05-071916431974
   PubMed Web of Science ®Google Scholar
• Woodell A, Jones BW, Williamson T, et al. A targeted inhibitor of the alternative complement pathway accelerates recovery from smoke-induced ocular injury. Invest Ophthalmol Vis Sci. 2016;57(4):1728–1737. doi:10.1167/iovs.15-1847127064393
   PubMed Web of Science ®Google Scholar
• Vu KT, Hulleman JD. An inducible form of Nrf2 confers enhanced protection against acute oxidative stresses in RPE cells. Exp Eye Res. 2017;164:31–36. doi:10.1016/j.exer.2017.08.00128782506
   PubMed Web of Science ®Google Scholar
• Zhang L, Vijg J. Somatic mutagenesis in mammals and its implications for human disease and aging. Annu Rev Genet. 2018;52:397–419. doi:10.1146/annurev-genet-120417-03150130212236
   PubMed Web of Science ®Google Scholar
• Wyss-Coray T. Ageing, neurodegeneration and brain rejuvenation. Nature. 2016;539(7628):180–186. doi:10.1038/nature2041127830812
   PubMed Web of Science ®Google Scholar
• Hamczyk MR, Del Campo L, Andres V. Aging in the cardiovascular system: lessons from hutchinson-gilford progeria syndrome. Annu Rev Physiol. 2018;80:27–48. doi:10.1146/annurev-physiol-021317-12145428934587
   PubMed Web of Science ®Google Scholar
• Mertens J, Reid D, Lau S, Kim Y, Gage FH. Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu Rev Genet. 2018;52:271–293. doi:10.1146/annurev-genet-120417-03153430208291
   PubMed Web of Science ®Google Scholar
• Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412–420. doi:10.1038/nrrheum.2016.6527192932
   PubMed Web of Science ®Google Scholar
• Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194–1217. doi:10.1016/j.cell.2013.05.03923746838
   PubMed Web of Science ®Google Scholar
• Wang AS, Dreesen O. Biomarkers of cellular senescence and skin aging. Front Genet. 2018;9:247. doi:10.3389/fgene.2018.0017330190724
   PubMed Web of Science ®Google Scholar
• Gluck S, Ablasser A. Innate immunosensing of DNA in cellular senescence. Curr Opin Immunol. 2018;56:31–36. doi:10.1016/j.coi.2018.09.01330296662
   PubMed Web of Science ®Google Scholar
• Kerur N, Fukuda S, Banerjee D, et al. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration. Nat Med. 2018;24(1):50–61. doi:10.1038/nm.445029176737
   PubMed Web of Science ®Google Scholar
• Nadal-Nicolas FM, Vidal-Sanz M, Agudo-Barriuso M. The aging rat retina: from function to anatomy. Neurobiol Aging. 2018;61:146–168. doi:10.1016/j.neurobiolaging.2017.09.02129080498
   PubMed Web of Science ®Google Scholar
• El-Sayyad HI, Khalifa SA, El-Sayyad FI, Mousa SA, Mohammed EA. Analysis of fine structure and biochemical changes of retina during aging of Wistar albino rats. Clin Experiment Ophthalmol. 2014;42(2):169–181. doi:10.1111/ceo.1212323601433
   PubMed Web of Science ®Google Scholar
• Fisher CR, Ferrington DA. Perspective on AMD pathobiology: a bioenergetic crisis in the RPE. Invest Ophthalmol Vis Sci. 2018;59(4):AMD41–AMD47. doi:10.1167/iovs.18-2428930025108
   PubMed Web of Science ®Google Scholar
• Tamiya S, Kaplan HJ. Role of epithelial-mesenchymal transition in proliferative vitreoretinopathy. Exp Eye Res. 2016;142:26–31. doi:10.1016/j.exer.2015.02.00826675400
   PubMed Web of Science ®Google Scholar
• Xia T, Rizzolo LJ. Effects of diabetic retinopathy on the barrier functions of the retinal pigment epithelium. Vision Res. 2017;139:72–81. doi:10.1016/j.visres.2017.02.00628347688
   PubMed Web of Science ®Google Scholar
• Zhu W, Meng YF, Xing Q, Tao JJ, Lu J, Wu Y. Identification of lncRNAs involved in biological regulation in early age-related macular degeneration. Int J Nanomedicine. 2017;12:7589–7602. doi:10.2147/IJN.S14027529089757
   PubMed Web of Science ®Google Scholar
• Nagineni CN, Samuel W, Nagineni S, et al. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J Cell Physiol. 2003;197(3):453–462. doi:10.1002/jcp.1037814566975
   PubMed Web of Science ®Google Scholar
• Liegl R, Koenig S, Siedlecki J, Haritoglou C, Kampik A, Kernt M. Temsirolimus inhibits proliferation and migration in retinal pigment epithelial and endothelial cells via mTOR inhibition and decreases VEGF and PDGF expression. PLoS One. 2014;9(2):e88203. doi:10.1371/journal.pone.008820324586308
   PubMed Web of Science ®Google Scholar
• Wang L, Li P, Tian Y, et al. Human umbilical cord mesenchymal stem cells: subpopulations and their difference in cell biology and effects on retinal degeneration in RCS rats. Curr Mol Med. 2017;17(6):421–435. doi:10.2174/156652401866617120514080629210653
   PubMed Web of Science ®Google Scholar
• Qin T, Gao S. Inhibition of proteasome activity upregulates IL-6 expression in RPE cells through the activation of P38 MAPKs. J Ophthalmol. 2018;2018:5392432. doi:10.1155/2018/539243230116631
   PubMed Web of Science ®Google Scholar
• Zhang S, Yu N, Zhang R, Zhang S, Wu J. Interleukin-17A induces IL-1beta secretion from RPE cells via the NLRP3 inflammasome. Invest Ophthalmol Vis Sci. 2016;57(2):312–319. doi:10.1167/iovs.15-1757826830368
   PubMed Web of Science ®Google Scholar
• Ghosh K, Capell BC. The senescence-associated secretory phenotype: critical effector in skin cancer and aging. J Invest Dermatol. 2016;136(11):2133–2139. doi:10.1016/j.jid.2016.06.62127543988
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Tarantini S, Donato AJ, Galvan V, Csiszar A. Mechanisms of vascular aging. Circ Res. 2018;123(7):849–867. doi:10.1161/CIRCRESAHA.118.31137830355080
   PubMed Web of Science ®Google Scholar
• Marazita MC, Dugour A, Marquioni-Ramella MD, Figueroa JM, Suburo AM. Oxidative stress-induced premature senescence dysregulates VEGF and CFH expression in retinal pigment epithelial cells: implications for age-related macular degeneration. Redox Biol. 2016;7:78–87. doi:10.1016/j.redox.2015.11.01126654980
   PubMed Web of Science ®Google Scholar
• Martinez-Zamudio RI, Robinson L, Roux PF, Bischof O. SnapShot: cellular senescence pathways. Cell. 2017;170(4):816–816 e811. doi:10.1016/j.cell.2017.07.04928802049
   PubMedGoogle Scholar
• Chroma K, Mistrik M, Moudry P, et al. Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress. Oncogene. 2017;36(17):2405–2422. doi:10.1038/onc.2016.39227841863
   PubMed Web of Science ®Google Scholar
• Kujoth GC, Hiona A, Pugh TD, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309(5733):481–484. doi:10.1126/science.111212516020738
   PubMed Web of Science ®Google Scholar
• Blasiak J, Piechota M, Pawlowska E, Szatkowska M, Sikora E, Kaarniranta K. Cellular senescence in age-related macular degeneration: can autophagy and dna damage response play a role? Oxid Med Cell Longev. 2017;2017:5293258. doi:10.1155/2017/529325829225722
   PubMed Web of Science ®Google Scholar
• Chen Q, Sun L, Chen ZJ. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat Immunol. 2016;17(10):1142–1149. doi:10.1038/ni.355827648547
   PubMed Web of Science ®Google Scholar
• Ahlers LR, Goodman AG. Nucleic acid sensing and innate immunity: signaling pathways controlling viral pathogenesis and autoimmunity. Curr Clin Microbiol Rep. 2016;3(3):132–141. doi:10.1007/s40588-016-0043-527857881
   PubMedGoogle Scholar
• Mathur V, Burai R, Vest RT, et al. Activation of the STING-dependent type i interferon response reduces microglial reactivity and neuroinflammation. Neuron. 2017;96(6):1290–1302 e1296. doi:10.1016/j.neuron.2017.11.03229268096
   PubMed Web of Science ®Google Scholar
• Yang H, Wang H, Ren J, Chen Q, Chen ZJ. cGAS is essential for cellular senescence. Proc Natl Acad Sci U S A. 2017;114(23):E4612–E4620. doi:10.1073/pnas.170549911428533362
   PubMed Web of Science ®Google Scholar
• Haag SM, Gulen MF, Reymond L, et al. Targeting STING with covalent small-molecule inhibitors. Nature. 2018;559(7713):269–273. doi:10.1038/s41586-018-0287-829973723
   PubMed Web of Science ®Google Scholar